Abstract:Objective To explore the diagnostic value of D-dimer and serum albumin combined with HE4 in patients with early ovarian cancer. Methods Totally 50 patients diagnosed with ovarian cancer (disease group) in our hospital from June 2015 to December 2016 and 44 patients with benign ovarian tumor (control group) were involved in this study. Clinical information was recorded. Single factor analysis was performed to identify differentially recorded factors. Multifactor logistic regression analysis was utilized to specify risk as well as protective factors. Correlation of factors with CA125 and their diagnostic value were analyzed by Pearson correlation analysis and ROC curve, respectively. Results Obvious difference in serum CA125, CA199, HE4, D-dimer, serum albumin AFP and ROMA index were founded between disease group and control group (P < 0.05). Logistic analysis showed that D-dimer, ROMA index, HE4 and CA125 were risk factors for ovarian cancer with O^R equal to 1.421 (95% CI: 1.164, 1.481, P = 0.037), 1.478 (95% CI: 1.292, 1.470, P = 0.034), 1.327 (95% CI: 1.011, 1.743, P = 0.042), 1.362 (95% CI: 1.305 and 1.638, P = 0.040). Serum albumin was a protective factor with O^R equal to 0.746 (95% CI: 0.687, 0.953, P = 0.039). Pearson correlation analysis indicated that D-dimer (r = 0.412), HE4 (r = 0.563) and ROMA index (r = 0.684) were positively related while serum albumin (r = -0.432) was negatively related with CA125 (P < 0.05). ROC curve suggested that AUC for serum albumin + HE4, D-dimer + HE4, serum CA125 and ROMA index were 0.859, 0.765, 0.654 and 0.700, respectively. Sensitivity and specificity of serum albumin combined with HE4 were 78.4% and 100%, respectively. Conclusion Serum albumin combined with HE4 is promising in diagnosis of early ovarian cancer.